C17H23N3O2
Neat
301.39
313369-26-5; T62S5ZZR2P; DTXSID201105564; Ethyl (6bR, 10aS)-2, 3, 6b, 9, 10, 10a-hexahydro-3-methyl-1H-pyrido(3', 4':4, 5)pyrrolo(1, 2, 3-de)quinoxaline-8(7H)-carboxylate; Ethyl (6bR, 10aS)-2, 3, 6b, 9, 10, 10a-hexahydro-3-methyl-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylate; RefChem:1084688; DTXCID101537235; (6bR, 10aS)-Ethyl 3-methyl-2, 3, 6b, 7, 10, 10a-hexahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(9H)-carboxylate; MFCD30730050; Ethyl (10R, 15S)-4-methyl-1, 4, 12-triazatetracyclo[7.6.1.05, 16.010, 15]hexadeca-5, 7, 9(16)-triene-12-carboxylate; ethyl (6bR, 10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylate; SCHEMBL3312456; SCHEMBL29963913; WHCUAJCNKSIETM-KBPBESRZSA-N; 1H-Pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylic acid, 2, 3, 6b, 9, 10, 10a-hexahydro-3-methyl-, ethyl ester, (6bR and 10aS)-; AKOS030228703; Lumateperone Impurity 13and enantiomer; DS-3444; SY266248; CS-0120041
ethyl (10R, 15S)-4-methyl-1, 4, 12-triazatetracyclo[7.6.1.05, 16.010, 15]hexadeca-5, 7 and 9(16)-triene-12-carboxylate
InChI=1S/C17H23N3O2/c1-3-22-17(21)19-8-7-14-13(11-19)12-5-4-6-15-16(12)20(14)10-9-18(15)2/h4-6,13-14H,3,7-11H2,1-2H3/t13-,14-/m0/s1